Goldenwell Biotech, Inc.
GWLL
$0.20
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -134.90K | -131.60K | -125.40K | -137.70K | -114.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.50K | 10.50K | 3.60K | 3.60K | 3.60K |
| Change in Net Operating Assets | 200.00 | 100.00 | 700.00 | 900.00 | 900.00 |
| Cash from Operations | -124.40K | -121.10K | -121.10K | -133.20K | -110.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 119.30K | 119.30K | 134.90K | 164.90K | 115.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.10K | -2.10K | -21.00K | -23.10K | -25.20K |
| Cash from Financing | 117.20K | 119.30K | 116.00K | 143.90K | 92.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.20K | -3.90K | -7.20K | 8.60K | -19.80K |